Phase I/II trial of carboplatin plus CPT-11 chemotherapy with accelerated hyperfractionated radiotherapy for elderly patients with limited stage small cell lung cancer (TORG0604).
Phase of Trial: Phase I/II
Latest Information Update: 01 May 2017
At a glance
- Drugs Carboplatin (Primary) ; Irinotecan (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions
- 11 Oct 2016 Final analysis results assessing safety and efficacy presented at the 41st European Society for Medical Oncology Congress.
- 26 Sep 2015 Status changed from recruiting to completed, as per University Hospital Medical Information Network - Japan record.
- 09 Sep 2015 Results presented at the 16th World Conference on Lung Cancer.